$SRGZ

Star Gold posts PEA: $87M pre-tax NPV (5%), 48% IRR; $67M after-tax NPV at $3,600/oz Au

Star Gold Corp. released a positive Preliminary Economic Assessment for Longstreet, showing a pre-tax NPV (5%) of $87M and a pre-tax IRR of 48% at $3,600/oz gold. After-tax NPV (5%) is $67M with an IRR of 40%. The project estimates lifetime production of 88,587 oz gold and 354,701 oz silver, with initial capital estimated at $70M.

Original reporting
Published Oct 7, 2026, 10:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 10:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Star Gold posts PEA: $87M pre-tax NPV (5%), 48% IRR; $67M after-tax NPV at $3,600/oz Au — source image
Decision brief

The 30-second read

$SRGZBullishLow
01

Why it matters

The disclosed NPV and IRR provide the first quantitative view of the project's economics, offering a new data point for valuation.

02

Market read

First‑time disclosure of project economics may attract speculative interest in the stock.

03

What to watch

Financing requirements, permitting risk, and gold price volatility could dampen the project's value.

Relevance 6/10Novelty 6/10Timing: today

Background

Star Gold Corp. filed an 8‑K on Oct 6, 2026 announcing its Longstreet PEA.

Company-level read

Ticker impact

$SRGZBullishMedium confidence
Context

Star Gold disclosed a positive Preliminary Economic Assessment with a pre‑tax NPV5% of $87 M and IRR of 48% for its Longstreet project.

Expected impact

possible upside as market prices in the favorable NPV and IRR figures

Evidence & confidence

PEA numbers are fresh and material for a junior miner; however, execution risk and early‑stage status limit certainty.

Market effects

May boost sentiment toward junior gold miners and exploration stocks.

Limited to North American mining sector.

Low; impact confined to investors tracking gold exploration projects.

Counterpoint

The PEA could be overly optimistic; actual costs and production may fall short, limiting upside.

Key entities

  • Star Gold Corp.

    Junior gold miner reporting the PEA.

Related articles

$UTHRMed

United Therapeutics Gets FDA Clearance To Begin Trial Of Inhaled PAH Therapy

United Therapeutics (UTHR) received FDA clearance to start clinical trials for Treprostinil-Iloprost SMI, an inhaled therapy for pulmonary arterial hypertension (PAH). The Phase 1 trial will assess safety and pharmacokinetics in healthy volunteers. If successful, a Phase 2 trial in PAH patients is planned for 2027. UTHR stock closed at $591.20, down 0.28%.

$HUBBMed

Wells Fargo cuts Hubbell stock price target on margin pressures

Wells Fargo reduced Hubbell's (HUBB) price target to $525 from $531, citing margin pressures and mixed Q3 results. The stock trades at $434 with a P/E of 25.6. Hubbell reported Q3 earnings of $5.91 per share, beating estimates, but guided Q4 below expectations due to cost pressures. The company expects 9% organic growth next year but faces margin challenges.